Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill

NCT01073800 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01073800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01073800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
Lead sponsor
University of Alberta
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2009
Completion date
September 30, 2011
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction, renal failure, stroke